Elanco Animal Health Inc
ELAN25.200USD
+0.890+3.66%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
12.52B시가총액
348.40P/E TTM
자세한 내용은 Elanco Animal Health Inc 회사
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Elanco Animal Health Inc 정보
종목 코드 ELAN
회사 이름Elanco Animal Health Inc
상장일Sep 20, 2018
CEOSimmons (Jeffrey N)
직원 수9000
유형Ordinary Share
회계 연도 종료Sep 20
주소450 Elanco Circle
도시INDIANAPOLIS
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호46221
전화18773526261
웹사이트https://www.elanco.com/
종목 코드 ELAN
상장일Sep 20, 2018
CEOSimmons (Jeffrey N)
Elanco Animal Health Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.36M
+632367.00%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
205.68K
+14943.00%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
170.34K
+10000.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
109.58K
+10314.00%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
91.28K
+10314.00%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
89.71K
+10314.00%
Mr. Paul S. Herendeen
Mr. Paul S. Herendeen
Independent Director
Independent Director
84.81K
+10314.00%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
80.40K
-23558.00%
Mr. James Meer
Mr. James Meer
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
62.55K
-1161.00%
Ms. Shiv O'Neill
Ms. Shiv O'Neill
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
53.92K
+27068.00%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.36M
+632367.00%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
205.68K
+14943.00%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
170.34K
+10000.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
109.58K
+10314.00%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
91.28K
+10314.00%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
89.71K
+10314.00%
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Farm Animal
593.00M
52.15%
Pet Health
533.00M
46.88%
Contract Manufacturing
11.00M
0.97%
지역별USD
이름
수익
비율
International
590.00M
51.89%
United States
547.00M
48.11%
사업별
지역별
사업별USD
이름
수익
비율
Farm Animal
593.00M
52.15%
Pet Health
533.00M
46.88%
Contract Manufacturing
11.00M
0.97%
주식 보유 통계
마지막 업데이트: Sun, Nov 16
마지막 업데이트: Sun, Nov 16
주주
주주 유형
주주
주주
비율
Dodge & Cox
16.66%
Fidelity Management & Research Company LLC
10.21%
PRIMECAP Management Company
10.05%
The Vanguard Group, Inc.
9.65%
BlackRock Institutional Trust Company, N.A.
8.13%
기타
45.30%
주주
주주
비율
Dodge & Cox
16.66%
Fidelity Management & Research Company LLC
10.21%
PRIMECAP Management Company
10.05%
The Vanguard Group, Inc.
9.65%
BlackRock Institutional Trust Company, N.A.
8.13%
기타
45.30%
주주 유형
주주
비율
Investment Advisor
68.93%
Investment Advisor/Hedge Fund
36.91%
Hedge Fund
5.77%
Research Firm
1.90%
Individual Investor
1.13%
Pension Fund
1.09%
Bank and Trust
0.63%
Sovereign Wealth Fund
0.18%
Family Office
0.13%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
898
573.48M
115.42%
-37.51M
2025Q3
891
577.57M
121.95%
+32.95M
2025Q2
878
543.55M
113.98%
+36.20M
2025Q1
945
503.90M
116.31%
-73.53M
2024Q4
964
498.16M
117.36%
+7.74M
2024Q3
970
490.73M
118.81%
+19.54K
2024Q2
1004
491.01M
118.24%
+1.27M
2024Q1
1021
489.85M
119.72%
-100.34M
2023Q4
1018
489.74M
120.73%
-3.72M
2023Q3
1027
490.57M
119.00%
+3.49M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Dodge & Cox
82.76M
16.66%
-135.40K
-0.16%
Sep 30, 2025
Fidelity Management & Research Company LLC
50.74M
10.21%
+2.50M
+5.18%
Sep 30, 2025
PRIMECAP Management Company
49.96M
10.05%
-1.81M
-3.49%
Sep 30, 2025
The Vanguard Group, Inc.
48.46M
9.75%
+816.50K
+1.71%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
40.42M
8.13%
+20.84M
+106.48%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
31.51M
6.34%
+11.96M
+61.14%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
24.71M
4.97%
+1.96M
+8.63%
Sep 30, 2025
State Street Investment Management (US)
15.25M
3.07%
+6.12M
+67.04%
Sep 30, 2025
Black Creek Investment Management, Inc.
12.48M
2.51%
-6.77M
-35.16%
Sep 30, 2025
Fidelity Institutional Asset Management
14.62M
2.94%
-2.03M
-12.17%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares U.S. Pharmaceuticals ETF
4.06%
Adaptiv Select ETF
3.38%
State Street SPDR S&P Pharmaceuticals ETF
3.15%
Brandes US Small-Mid Cap Value ETF
3.14%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.84%
VanEck Agribusiness ETF
2.3%
First Trust Health Care Alphadex Fund
1.92%
Federated Hermes MDT Large Cap Value ETF
1.9%
First Trust NASDAQ Pharmaceuticals ETF
1.33%
Invesco S&P MidCap 400 Pure Value ETF
1.22%
더 보기
iShares U.S. Pharmaceuticals ETF
비율4.06%
Adaptiv Select ETF
비율3.38%
State Street SPDR S&P Pharmaceuticals ETF
비율3.15%
Brandes US Small-Mid Cap Value ETF
비율3.14%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
비율2.84%
VanEck Agribusiness ETF
비율2.3%
First Trust Health Care Alphadex Fund
비율1.92%
Federated Hermes MDT Large Cap Value ETF
비율1.9%
First Trust NASDAQ Pharmaceuticals ETF
비율1.33%
Invesco S&P MidCap 400 Pure Value ETF
비율1.22%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
